Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

TeraWulf (WULF) Stock News, Forecasts and Analysis: AI Data Center Pivot, Preferred Conversion, Local Zoning Risk and Wall Street Targets (Dec. 15, 2025)

TeraWulf (WULF) Stock News, Forecasts and Analysis: AI Data Center Pivot, Preferred Conversion, Local Zoning Risk and Wall Street Targets (Dec. 15, 2025)

TeraWulf Inc. (NASDAQ: WULF) has become one of the market’s most closely watched “power + compute” stories—part bitcoin miner, part next-generation data center landlord for high‑performance computing (HPC) and AI workloads. On December 15, 2025, the stock is hovering around
Kellanova Stock (NYSE: K) Update on Dec. 15, 2025: Mars Deal Closes, $83.50 Cash Payout, Dividend Details, and What Investors Should Know

Kellanova Stock (NYSE: K) Update on Dec. 15, 2025: Mars Deal Closes, $83.50 Cash Payout, Dividend Details, and What Investors Should Know

December 15, 2025 — Kellanova stock (NYSE: K) has effectively reached its end as a publicly traded investment following Mars’ completed acquisition of the Pringles and Cheez-It maker. The transaction—announced last year at $83.50 per share in cash—closed on December
NVIDIA Stock (NVDA) News, Forecasts and Analysis for Dec. 15, 2025: China’s H200 Demand, Export Policy Shifts, and “AI ROI” Jitters Collide

NVIDIA Stock (NVDA) News, Forecasts and Analysis for Dec. 15, 2025: China’s H200 Demand, Export Policy Shifts, and “AI ROI” Jitters Collide

Dec. 15, 2025 — NVIDIA Corporation stock (NASDAQ: NVDA) is starting the week with investors pulled in two directions at once: renewed optimism that China demand could reopen a major revenue lane for NVIDIA’s high-end AI chips, and fresh anxiety
Netflix Stock (NFLX) News Today: Warner Bros Deal Reaffirmed, Analyst Price Targets Shift, and the 2026 Outlook (Dec. 15, 2025)

Netflix Stock (NFLX) News Today: Warner Bros Deal Reaffirmed, Analyst Price Targets Shift, and the 2026 Outlook (Dec. 15, 2025)

Netflix, Inc. stock (NASDAQ: NFLX) is back in the spotlight on Monday, December 15, 2025—less because of streaming metrics and more because the company is trying to do something it famously avoided for years: buy a legacy Hollywood empire. As
Ondas Holdings (ONDS) Stock: Latest News, Debt Exchange Update, and Analyst Forecasts for December 15, 2025

Ondas Holdings (ONDS) Stock: Latest News, Debt Exchange Update, and Analyst Forecasts for December 15, 2025

Ondas Holdings Inc. (NASDAQ: ONDS) is starting the week in focus as investors weigh a fast-moving mix of defense-drone catalysts, rail communications strategy, and a fresh SEC filing outlining a proposed exchange of subsidiary-level notes and warrants—a move that could
Warner Bros. Discovery (WBD) Stock Today: Netflix Deal, Paramount Hostile Bid, and Analyst Forecasts as Shares Hover Near $30 (Dec. 15, 2025)

Warner Bros. Discovery (WBD) Stock Today: Netflix Deal, Paramount Hostile Bid, and Analyst Forecasts as Shares Hover Near $30 (Dec. 15, 2025)

Warner Bros. Discovery, Inc. (NASDAQ: WBD) has abruptly turned into the stock market’s favorite kind of chaos: an event-driven tug-of-war where headlines move faster than quarterly fundamentals. As of Monday, December 15, 2025, WBD shares traded around $29.98 in the
Oracle Stock (ORCL) News Today (Dec. 15, 2025): $50B AI Capex Shock, OpenAI Data Center Questions, and Wall Street Forecasts

Oracle Stock (ORCL) News Today (Dec. 15, 2025): $50B AI Capex Shock, OpenAI Data Center Questions, and Wall Street Forecasts

Dec. 15, 2025 — Oracle Corporation (NYSE: ORCL) is starting this week in a market mood that can best be described as “AI sobriety, with a side of whiplash.” Shares were trading around $190 on Monday after last week’s sharp
Kenvue Stock (KVUE) Today: Latest News, Deal Outlook, Analyst Forecasts and Key Risks (Dec. 15, 2025)

Kenvue Stock (KVUE) Today: Latest News, Deal Outlook, Analyst Forecasts and Key Risks (Dec. 15, 2025)

Kenvue Inc. (NYSE: KVUE)—the consumer health company behind brands such as Tylenol, Band-Aid, Listerine, Neutrogena, and Aveeno—is trading in a market that feels less like “buy-and-hold fundamentals” and more like “event-driven probability.” The reason: Kimberly-Clark’s planned acquisition of Kenvue, a
1 90 91 92 93 94 315
Go toTop